
Ethawk 250mg Tablet
Marketer
Wockhardt Ltd
Salt Composition
Ethamsylate (250mg)
Overview Ethawk 250mg Tablet
Transepsis 250mg tablets effectively manage hemorrhaging. This medication is indicated for preventing or lessening blood loss associated with menstrual irregularities, dysfunctional uterine bleeding, and surgical procedures. Transepsis 250mg is a hemostatic agent that promotes platelet aggregation, facilitating clot formation and stemming capillary bleeding. Adhere strictly to your physician's prescribed dosage and regimen for optimal therapeutic effect. Commonly reported adverse reactions include nausea, headache, diarrhea, vomiting, and skin rash. Report any such reactions to your doctor for appropriate management. Prior to commencing treatment, disclose any pre-existing liver, heart, or kidney conditions, and any known allergies to this medication.
Uses of Ethawk 250mg Tablet
Hemorrhage
Major Benefits of Ethawk 250mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Ethawk 250mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ethawk 250mg Tablet:
- Skin rash
- Vomiting
- Headache
- Nausea
- Diarrhea
How to use Ethawk 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ethawk 250mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Ethawk 250mg Tablet works:
Hemostatin Ethawk 250mg tablets promote blood clotting. Their mechanism involves enhancing platelet aggregation, thereby facilitating clot formation and stemming capillary bleeding.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ethawk 250mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Ethawk 250mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ethawk 250mg Tablet with breastfeeding are lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ethawk 250mg Tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding Ethawk 250mg Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ethawk 250mg Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ethawk 250mg Tablet :
Should you forget to take your Ethawk 250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ethawk 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzenesulfonate compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Clot-promoting substance |
